Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Targeted radionuclide therapy in combined-modality regimens
HTML
PDF
Details
Locations
Year:
2017
Type:
review
Source:
The Lancet Oncology
DOI:
10.1016/s1470-2045(17)30379-0
Authors:
Martin R Gill,
Nadia Falzone,
Yong Du,
Katherine A Vallis
Institutions:
University of Oxford,
CRUK/MRC Oxford Institute for Radiation Oncology,
Royal Marsden NHS Foundation Trust,
Royal Marsden Hospital
Language:
English
Topic:
Radiopharmaceutical Chemistry and Applications
Subfield:
Radiology, Nuclear Medicine and Imaging
Field:
Medicine
Domain:
Health Sciences
Keywords:
targeted radionuclide therapy,
multimodal therapy,
radium-223 dichloride,
bone metastasis,
177Lu-DOTATATE,
neuroendocrine tumors,
yttrium-90 microspheres,
liver tumors,
radiolabeled antibodies,
radionuclides
show all 10
SDG:
Good health and well-being
Open Access status:
green
Funders:
Cancer Research UK,
Medical Research Council
Awards:
University of Oxford Confidence in Concept Scheme – Round 4,
G3814908810,
G5378598371,
G6415780385,
Molecular determinants of Radiosensitivity
OpenAlex ID:
W2731366479
FWCI:
2.319
Cites:
97
Cited by:
200
Related to:
10